{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260812443578/en/Ivonescimab-in-Combination-with-Chemotherapy-Approved-in-China-by-NMPA-for-First-Line-Treatment-of-Patients-with-Squamous-Non-Small-Cell-Lung-Cancer", "message": "News view counter 878152 successfully enlarged"}